Injectable magnesium oxychloride cement foam (mocf)-derived scaffold for treating osteoporotic bone defects
US-2024108785-A1 · Apr 4, 2024 · US
US9808557B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9808557-B2 |
| Application number | US-67252108-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 11, 2008 |
| Priority date | Aug 10, 2007 |
| Publication date | Nov 7, 2017 |
| Grant date | Nov 7, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Described are tubular silk fibroin compositions and methods for their manufacture and use. Tubular compositions as described herein can be produced in a range of high burst strengths, can easily be made in a range of inner diameters, can be derivatized with functional moieties, and can be produced in a range of permeabilities suitable for particularized uses. In one aspect, the tubular compositions can be used in the repair or replacement of damaged or diseased blood vessels, including, but not limited to vessels smaller than about 6 mm.
Opening claim text (preview).
The invention claimed is: 1. A tubular composition in which a silk fibroin material forms a wall that defines an inner lumen having a diameter of less than 6 mm, and has a structure, including pore size, wherein the tubular composition achieves a burst strength of at least 1680 mm Hg, and wherein said wall has an apparent permeability coefficient of 7.3×10 −4 +/−1.5×10 −4 cm/s or lower. 2. The composition of claim 1 , wherein the silk fibroin material comprises a plurality of layers of silk fibroin. 3. The composition of claim 1 , wherein the inner lumen diameter is 0.1 mm to 5.9 mm. 4. The composition of claim 1 , wherein said silk fibroin material is predominantly in a β-sheet conformation. 5. The composition of claim 1 , further comprising: at least one endothelial cell within the lumen and associated with the wall of the tubular composition. 6. The composition of claim 1 , wherein the silk fibroin material comprises a functional moiety coupled to silk fibroin. 7. The composition of claim 6 , wherein said functional moiety comprises an RGD peptide. 8. The composition of claim 1 , further comprising a bioactive material associated with the silk fibroin material. 9. The composition of claim 8 , wherein said bioactive material is selected from the group consisting of a cell, a peptide, a polypeptide and/or a therapeutic agent. 10. The tubular composition of claim 1 , wherein the silk fibroin material comprises silk fibroin and polyethylene oxide. 11. The composition of claim 10 , wherein the silk fibroin material comprises a plurality of layers. 12. The composition, of claim 1 , wherein the tubular composition is self-supporting in that it does not rely upon another material for its physical support or tubular shape. 13. The composition, of claim 12 , wherein the tubular composition is not a tubular construct in which a framework or support made of another material is coated with silk. 14. The composition of claim 12 , wherein the tubular composition is not a stent or other structure that carries a coating comprising or consisting of silk on inner or outer surfaces or both. 15. The tubular composition of claim 1 , wherein the burst strength is at least 2460 mm Hg. 16. The tubular composition of claim 1 , wherein the burst strength is at least 2470 mm Hg. 17. The tubular composition of claim 1 , wherein the burst strength is at least 2780 mm Hg. 18. A method of making the tubular composition of claim 1 , the method comprising steps of: (a) providing an aqueous preparation of silk fibroin; (b) contacting a rod of a selected diameter with the aqueous preparation of silk fibroin to coat the rod in silk fibroin; (c) drying the silk fibroin so that a silk fibroin material is formed as a coating on the rod; and (d) removing the silk fibroin material from the rod, the silk fibroin material being in a tubular shape, so that the tubular composition of claim 1 is prepared with a permeability coefficient of 7.2×10 −4 +/−1.5×10 −4 cm/s or lower. 19. The method of claim 18 , wherein steps (b)-(c) are repeated at least once, so that the silk fibroin material comprises at least two layers of silk fibroin. 20. The method of claim 18 , further comprising a step of contacting the rod with methanol after step (b). 21. The method of claim 18 , wherein the aqueous preparation of silk fibroin comprises polyethylene oxide, so that the silk fibroin material comprises silk fibroin and polyethylene oxide. 22. A method of repairing or replacing a blood vessel in a mammal in need thereof, the method comprising implanting in said mammal the tubular composition of claim 1 , wherein said implanting repairs or replaces the blood vessel in said mammal. 23. A kit comprising the tubular composition of claim 1 , and packaging materials therefor.
Muscles; Tendons; Ligaments · CPC title
Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents (stent-grafts for tubular structures of the body other than blood vessels A61F2/04; stent-grafts for blood vessels A61F2/07) · CPC title
characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel · CPC title
Fibroin · CPC title
Stent-grafts · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.